Amedeo Smart

Free Medical Literature Service

 

Amedeo

Leukemia
  Free Subscription

Articles published in
Exp Hematol
    October 2026
  1. SAFA-TAHAR-HENNI S, Milan T, DesCoteaux T, Roques E, et al
    Comparative analysis of KMT2A fusions in human models of acute myeloid leukemia.
    Exp Hematol. 2026 Oct 24:105955. doi: 10.1016/j.exphem.2026.105955.
    >> Share

  2. METODIEVA A, Karbanova J, Chiriches C, Mian AA, et al
    Prominin-1 (CD133) is essential for the determination of the phenotype of Philadelphia chromosome-positive leukemia.
    Exp Hematol. 2026 Oct 6:105918. doi: 10.1016/j.exphem.2026.105918.
    >> Share

    September 2026
  3. FENG J, Hao Q, Xu M, Jia Y, et al
    Effect of the dominant-negative Ikaros isoform 6 (Ik6) on cell function and drug sensitivity in Ph-positive acute lymphoblastic leukemia cell lines.
    Exp Hematol. 2026 Sep 13:105871. doi: 10.1016/j.exphem.2026.105871.
    >> Share

  4. KIM HN, Hurwitz S, Fourfouris T, Lee KJ, et al
    Integrin Alpha 4 Inhibition Prolongs the Survival of NSG Mice Engrafted with CD19-Negative Post-CART19 Relapsed B-ALL.
    Exp Hematol. 2026;161:105471.
    >> Share

    August 2026
  5. CALLERA AF, Ferreira CP, Rech DF, Rosa ES, et al
    Phenotypic Remodeling and Functional Impairment of Circulating Neutrophils Are Associated with Infection-Related Mortality in Acute Myeloid Leukemia.
    Exp Hematol. 2026 Aug 29:105872. doi: 10.1016/j.exphem.2026.105872.
    >> Share

  6. DUAN J, Zhang H, Chu J, Duan X, et al
    Prognostic model based on calcium-related genes predicts prognosis and reveals the immune landscape of acute myeloid leukemia.
    Exp Hematol. 2026 Aug 25:105870. doi: 10.1016/j.exphem.2026.105870.
    >> Share

  7. BHOWMIK S, Ghosh S, Sengupta A
    cGAS-STING signaling in acute myeloid leukemia: biology, pathophysiology and therapeutic implications.
    Exp Hematol. 2026 Aug 5:105490. doi: 10.1016/j.exphem.2026.105490.
    >> Share

  8. SUZUKI K, Watanabe N, Tsukune Y, Inano T, et al
    Peripheral blood profiles reflecting progenitor lineage balance are associated with molecular response in chronic myeloid leukemia.
    Exp Hematol. 2026 Aug 3:105488. doi: 10.1016/j.exphem.2026.105488.
    >> Share

  9. FAGNAN A
    From gamma to X: same destination but different journey?
    Exp Hematol. 2026;160:105445.
    >> Share

  10. HASANI R, Pourseif MM, Alizadeh E, Tohidkia MR, et al
    CD20-targeted immunotherapies in B-cell malignancies: mechanistic and clinical advances.
    Exp Hematol. 2026;160:105444.
    >> Share

    July 2026
  11. DONADA A
    MYC unchained: dosage-dependent locking of the myeloid fate (or not).
    Exp Hematol. 2026;159:105443.
    >> Share

    June 2026
  12. RAJHANSA S, Crump NT, Khoo HM, Dopico-Fernandez A, et al
    Inhibition of MLLT1 limits growth of KMT2A::AFF1 leukaemias without killing healthy haematopoietic stem cells.
    Exp Hematol. 2026 Jun 3:105458. doi: 10.1016/j.exphem.2026.105458.
    >> Share

    May 2026
  13. STOKES N, Carcamo S, Demircioglu D, Wang X, et al
    Sustained MYC overexpression drives myeloid differentiation block and acquisition of leukemic phenotypes.
    Exp Hematol. 2026;157:105403.
    >> Share

  14. DAVID S, Nye GJ, Eudy E, Bolcun-Filas E, et al
    Functional equivalence of gamma- and x-ray irradiation for long-term peripheral blood chimerism and acute myeloid leukemia transplant outcomes in mice.
    Exp Hematol. 2026;157:105385.
    >> Share

    April 2026
  15. ISOBE T, Meggendorfer M, Wolf S, Oellerich T, et al
    Stem11 score: towards rapid clinical prognostication for acute myeloid leukemia.
    Exp Hematol. 2026 Apr 17:105441. doi: 10.1016/j.exphem.2026.105441.
    >> Share

  16. SHAH R, Kingston N, Fabbri G, Saeh J, et al
    Evaluation of dual BCL-2/BCL-XL inhibition in acute myeloid leukemia preclinical models with and without prior venetoclax therapy.
    Exp Hematol. 2026;156:105379.
    >> Share

    March 2026
  17. HAMED M, Kovecses O, McKeague M
    Current landscape of mRNA therapeutics for acute myeloid leukemia.
    Exp Hematol. 2026 Mar 17:105406. doi: 10.1016/j.exphem.2026.105406.
    >> Share

  18. UEDA K, Sato Y, Minakawa K, Miura S, et al
    Loss of Ezh2 precipitates lethal disease progression in a mouse model of Calr-mutated myeloproliferative neoplasms.
    Exp Hematol. 2026;155:105350.
    >> Share

  19. NISHIKII H, Kikuchi R, Kimura T, Saito M, et al
    Tumor necrosis factor from leukemic environment stimulates hematopoietic stem/progenitor cells toward megakaryocyte/myeloid lineage bias.
    Exp Hematol. 2026;155:105332.
    >> Share

    February 2026
  20. LIU X, Zhang Y, Hua S, Shao X, et al
    Gremlin-1 promotes leukemic survival via PI3K/AKT signaling in infant MLL-AF4-positive B-cell acute lymphoblastic leukemia.
    Exp Hematol. 2026 Feb 25:105402. doi: 10.1016/j.exphem.2026.105402.
    >> Share

  21. YAN Y, Kato H, Sano S, Furukawa E, et al
    Heme Synthesis Inhibition Induces the Intrinsic Apoptosis Pathway in Leukemia with OSGIN1 Upregulation.
    Exp Hematol. 2026 Feb 13:105401. doi: 10.1016/j.exphem.2026.105401.
    >> Share

  22. KHAN AB, Huntly BJP
    Taking the direct route: menin inhibitors go straight to the frontline in KMT2A-rearranged acute leukemia.
    Exp Hematol. 2026 Feb 4:105386. doi: 10.1016/j.exphem.2026.105386.
    >> Share

  23. DUGUID A, Malouf C, Nitsche L, Halsey C, et al
    Mixed-lineage leukemia cells undergo unique adaptations in the CNS niche.
    Exp Hematol. 2026;154:105347.
    >> Share

  24. IAQUINTA G, Lagana A, Tamburini A, Tatarelli C, et al
    Germline heterozygous SH2B3 p.Glu78Lys variant: a three-patient case series with myeloproliferative neoplasms.
    Exp Hematol. 2026;154:105333.
    >> Share

    January 2026
  25. MAHDAVI L, Alikarami F, Goodrow H, Lenard A, et al
    Upfront menin-inhibitor resistance in multiply pretreated leukemias.
    Exp Hematol. 2026;153:105268.
    >> Share

    December 2025
  26. GORSCH E, Rudat S, Arnone M, Keppeler H, et al
    Laminin Receptor Characterization in Acute Myeloid Leukemia: Integrin alpha7beta1 Defines leukemic cells with Migratory Potential.
    Exp Hematol. 2025 Dec 25:105363. doi: 10.1016/j.exphem.2025.105363.
    >> Share

  27. WANG J, Xu J
    Splenic Erythroblasts Fuels Leukemia Progression Through Metabolic Crosstalk.
    Exp Hematol. 2025 Dec 15:105351. doi: 10.1016/j.exphem.2025.105351.
    >> Share

    November 2025
  28. ROY R, Paul T, Das PK, Sinha S, et al
    ERK-mTOR crosstalk suppresses Autophagy and upregulates proteasomal degradation pathway to confer Chronic Myeloid Leukemia cells resistant to Imatinib.
    Exp Hematol. 2025 Nov 28:105330. doi: 10.1016/j.exphem.2025.105330.
    >> Share

  29. VARGHESE P, Garcia-Cuellar MP, Slany RK
    The myeloid transcription factor Elf1 regulates genes with function in innate immunity.
    Exp Hematol. 2025;151:104864.
    >> Share

    October 2025
  30. CONNEELY SE, Quezada A, Kurtz KJ, Zhang N, et al
    Cohesin haploinsufficiency is tolerated in Cbfb::MYH11-driven murine acute myeloid leukemia.
    Exp Hematol. 2025 Oct 29:105287. doi: 10.1016/j.exphem.2025.105287.
    >> Share

    September 2025
  31. ERNST P, Kyei P, Yokoyama A
    KMT2A-rearranged leukemia: from mechanism to drug development.
    Exp Hematol. 2025 Sep 6:105247. doi: 10.1016/j.exphem.2025.105247.
    >> Share

  32. SANGHA G, Huntly BJP
    Gene regulatory complexes: their role and regulation across normal and malignant hematopoiesis.
    Exp Hematol. 2025;149:104821.
    >> Share

  33. YOSHIDA S, Onozawa M, Yokoyama S, Matsukawa T, et al
    Peposertib suppresses generation of FLT3-internal tandem duplication formed by contralateral double nicks.
    Exp Hematol. 2025;149:104819.
    >> Share

    August 2025
  34. WANG J, Xu L, Wang G, Wu W, et al
    ZC3H13 facilitates the progression of acute myeloid leukemia through m6A-FOXP1-mediated metabolic reprogramming.
    Exp Hematol. 2025 Aug 6:104862. doi: 10.1016/j.exphem.2025.104862.
    >> Share

  35. SAMAREH B, Klimenkova O, Aghaallaei N, Cheng L, et al
    NAMPT-mediated deacetylation of HCLS1 protein promotes clonogenic growth of pediatric CML cells.
    Exp Hematol. 2025;148:104801.
    >> Share

    July 2025
  36. FOSSELTEDER J, Brauchart T, Schlacher A, Sconocchia T, et al
    Engineered cytokine-expressing MSCs support ex vivo culture of human HSPCs and AML cells.
    Exp Hematol. 2025;147:104790.
    >> Share

    June 2025
  37. ZHANG A, Qiu S
    Advances of RARalpha fusion genes in acute promyelocytic leukemia.
    Exp Hematol. 2025 Jun 7:104822. doi: 10.1016/j.exphem.2025.104822.
    >> Share

    May 2025
  38. LU J, Xue X, Wang H, Hao Y, et al
    Notch1 activation and inhibition in T cell acute lymphoblastic leukemia subtypes.
    Exp Hematol. 2025 May 8:104771. doi: 10.1016/j.exphem.2025.104771.
    >> Share

  39. CISA-WIECZOREK S, Hernandez-Alvarez MI, Parreno M, Munoz JP, et al
    D816V KIT mutation induces mitochondrial morphologic and functional changes through BNIP3 downregulation in human myeloid cell lines ROSA and TF-1.
    Exp Hematol. 2025;145:104748.
    >> Share

    April 2025
  40. FOURNIER M, Dubuissez M, Neault M, Delisle JS, et al
    Unbiased analysis of NUP98-KDM5A-induced murine leukemia reveals phenotypic heterogeneity recapitulating human disease subtypes.
    Exp Hematol. 2025 Apr 19:104791. doi: 10.1016/j.exphem.2025.104791.
    >> Share

    March 2025
  41. GUL AZ, Selek S, Bekiroglu S, Demirel M, et al
    Serum NMR metabolomics in distinct subtypes of hematologic malignancies.
    Exp Hematol. 2025;143:104710.
    >> Share

  42. SARCHI M, Doulatov S
    Understanding Human Oncogene Function and Cooperativity in Myeloid Malignancy Using iPSCs.
    Exp Hematol. 2025;143:104697.
    >> Share

  43. GUIRGUIS AA
    RNA methylation: where to from here for hematologic malignancies?
    Exp Hematol. 2025;143:104694.
    >> Share

    February 2025
  44. TACHIBANA T, Izumi A, Arai S, Takeda T, et al
    Preconditioning intervention before allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia.
    Exp Hematol. 2025 Feb 12:104746. doi: 10.1016/j.exphem.2025.104746.
    >> Share

  45. DE GROOT AP, Nguyen H, Pouw JS, Weersing E, et al
    CBX7 inhibitors affect H3K9 methyltransferase-regulated gene repression in leukemic cells.
    Exp Hematol. 2025;142:104691.
    >> Share

    January 2025
  46. AMOR AR, Enlund S, Sinha I, Jiang Q, et al
    A Distinct Alternative mRNA Splicing Profile Identifies the Oncogenic CD44 Transcript Variant 3 in KMT2A-Rearranged Pediatric T-cell Acute Lymphoblastic Leukemia Cells.
    Exp Hematol. 2025 Jan 8:104712. doi: 10.1016/j.exphem.2025.104712.
    >> Share

    November 2024
  47. QU Y, Shourabizadeh H, Subramanian A, Aleman DM, et al
    DIFFERENTIAL IMPACT OF CD34+ CELL DOSE FOR DIFFERENT AGE GROUPS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR ACUTE LEUKEMIA: A MACHINE LEARNING-BASED DISCOVERY.
    Exp Hematol. 2024 Nov 22:104684. doi: 10.1016/j.exphem.2024.104684.
    >> Share

    October 2024
  48. KOHNKE T, Feng Y, Majeti R
    A New Era of Functional Experimentation in Human Hematopoiesis and Leukemia Research.
    Exp Hematol. 2024 Oct 1:104652. doi: 10.1016/j.exphem.2024.104652.
    >> Share

    September 2024
  49. KHAMARI R, Degand C, Fovez Q, Trinh A, et al
    Key role of glutamine metabolism in persistence of leukemic cells upon exposition to FLT3 tyrosine kinase inhibitors.
    Exp Hematol. 2024;137:104253.
    >> Share

    August 2024
  50. CAMIOLO G, Mullen CG, Ottersbach K
    Mechanistic insights into the developmental origin of pediatric hematologic disorders.
    Exp Hematol. 2024;136:104583.
    >> Share

    June 2024
  51. ONG KOK, Mok MMH, Niibori-Nambu A, Du L, et al
    Activation of NOTCH signaling impedes cell proliferation and survival in acute megakaryoblastic leukemia.
    Exp Hematol. 2024 Jun 12:104255. doi: 10.1016/j.exphem.2024.104255.
    >> Share

  52. STRAUBE J, Janardhanan Y, Haldar R, Bywater MJ, et al
    Immune control in acute myeloid leukemia.
    Exp Hematol. 2024 Jun 12:104256. doi: 10.1016/j.exphem.2024.104256.
    >> Share

  53. ROGERS JH, Rosen A, Reyes JM, Ketkar S, et al
    Dose-dependent effects of Dnmt3a in an inducible murine model of Kras(G12D)-driven leukemia.
    Exp Hematol. 2024 Jun 2:104248. doi: 10.1016/j.exphem.2024.104248.
    >> Share

  54. XU JJ, Viny AD
    Chromatin organization in myelodysplastic syndrome.
    Exp Hematol. 2024;134:104216.
    >> Share

    May 2024
  55. ZHOU Q, Li Z, Xi Y
    EV-mediated intercellular communication in acute myeloid leukemia: Transport of genetic materials in the bone marrow microenvironment.
    Exp Hematol. 2024;133:104175.
    >> Share

    March 2024
  56. PANTING RG, Kotecha RS, Cheung LC
    The critical role of the bone marrow stromal microenvironment for development of drug screening platforms in leukemia.
    Exp Hematol. 2024 Mar 27:104212. doi: 10.1016/j.exphem.2024.104212.
    >> Share

  57. GOSWAMI M, Bose PD
    Gut Microbial Dysbiosis in the Pathogenesis of Leukemia: An Immune-based Perspective.
    Exp Hematol. 2024 Mar 23:104211. doi: 10.1016/j.exphem.2024.104211.
    >> Share

  58. LIU Q, Zhai Y, Hui Y, Chen J, et al
    Identification of Red blood cell distribution width as a prognostic factor in acute myeloid leukemia.
    Exp Hematol. 2024 Mar 18:104206. doi: 10.1016/j.exphem.2024.104206.
    >> Share

    February 2024
  59. TANAKA T, Kudo K, Kanezaki R, Yuzawa K, et al
    Anti-leukemic effect of azacitidine, a DNA methyltransferase inhibitor, on cell lines of myeloid leukemia associated with Down syndrome.
    Exp Hematol. 2024 Feb 9:104179. doi: 10.1016/j.exphem.2024.104179.
    >> Share

  60. RANDALL J, Evans K, Watts B, Kosasih HJ, et al
    IN VIVO ACTIVITY OF THE SECOND-GENERATION PROTEASOME INHIBITOR IXAZOMIB AGAINST PEDIATRIC T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA XENOGRAFTS.
    Exp Hematol. 2024 Feb 4:104176. doi: 10.1016/j.exphem.2024.104176.
    >> Share

  61. MERZ AMA, Platzbecker U
    Beyond the horizon: emerging therapeutic approaches in myelodysplastic neoplasms.
    Exp Hematol. 2024;130:104130.
    >> Share

    December 2023
  62. ALQAZZAZ MA, Luciani GM, Vu V, Machado RM, et al
    Epigenetic vulnerabilities of leukemia harboring inactivating EZH2 mutations.
    Exp Hematol. 2023 Dec 8:S0301-472X(23)01773-3. doi: 10.1016/j.exphem.2023.
    >> Share

  63. BUROCZIOVA M, Grusanovic S, Vanickova K, Kosanovic S, et al
    Chronic inflammation promotes cancer progression as a second hit.
    Exp Hematol. 2023;128:30-37.
    >> Share

    October 2023
  64. XIE Y, Tan L, Wu K, Li D, et al
    MiR-455-3p mediates PPARalpha through UBN2 to promote apoptosis and autophagy in acute myeloid leukemia cells.
    Exp Hematol. 2023 Oct 5:S0301-472X(23)01734-4. doi: 10.1016/j.exphem.2023.
    >> Share

    September 2023
  65. GUARNERA L, Santinelli E, Galossi E, Cristiano A, et al
    Microenvironment in Acute Myeloid Leukemia: focus on senescence mechanisms, therapeutic interactions and future directions.
    Exp Hematol. 2023 Sep 21:S0301-472X(23)01705.
    >> Share

  66. HAN L, Wu J, Lyu X, Yu J, et al
    Genetic Mutation Signature for Relapse Prediction in Normal Karyotype Acute Myeloid Leukemia.
    Exp Hematol. 2023 Sep 20:S0301-472X(23)01706.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016